Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Persistent Neuropathy in Lepromatous Leprosy Patients

Penna P, Vital R, Pitta I, et al. Research Square Platform LLC. 2021;
Download PDF
Publication

Delay in diagnosis as a prognostic factor for disability in patients with leprosy in Paraguay. Case and control study.

Aguilera M, Samaniego L, Samudio M. Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia. 2021; 38 (4) : 532-539.
Download PDF
Publication

Primary neural leprosy: clinical, neurophysiological and pathological presentation and progression.

Tomaselli P, Santos D, Santos A, et al. Brain : a journal of neurology. 2021;
Publication

A qualitative study on the implementation of a holistic care package for control and management of lymphoedema: experience from a pilot intervention in northern Ethiopia.

Ali O, Kinfe M, Semrau M, et al. BMC health services research. 2021; 21 (1) : 1065.
Download PDF
Publication

Effectiveness of self-care interventions for integrated morbidity management of skin neglected tropical diseases in Anambra State, Nigeria.

Eze C, Ekeke N, Alphonsus C, et al. BMC public health. 2021; 21 (1) : 1748.
Download PDF
Publication

A clinicopathological and electrophysiological study of nerve involvement in leprosy in a tertiary care centre in South India

Celine MI, Jaleel A, Palakkal S, et al. Lepra. Leprosy Review. 2021; 92 (3) : 225-235.
Download PDF
Publication

Characteristics of Grade 2 Disability in Indonesian Children with Leprosy: A Five-Year Multicenter Retrospective Study.

Gunawan H, Kamilia A, Menaldi S, et al. Clinical, cosmetic and investigational dermatology. 2021;
Download PDF
Publication

Disability Level, Physical Activity Limitations, Self-esteem and Self-efficacy of Persons Living with Leprosy in Selected States in Nigeria

Umunnah JO, Mmadieke OC, Amaechi IA, et al. Sierra Leone Journal of Biomedical Research. 2021; 13 (1) : 1-8.
Download PDF
Publication

Perception of cure among leprosy patients post completion of multi-drug therapy.

Rosendo dos Santos A, Silva P, Costa L, et al. BMC infectious diseases. 2021; 21 (1) : 916.
Download PDF

Pagination

  • Previous page ‹‹
  • Page 36
  • Next page ››
Subscribe to Disability

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2026 InfoNTD